Ardent Health Partners (NYSE:ARDT) Price Target Raised to $25.00

Ardent Health Partners (NYSE:ARDT) had its price target hoisted by Leerink Partners from $23.00 to $25.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

A number of other analysts have also commented on ARDT. KeyCorp initiated coverage on Ardent Health Partners in a research note on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective on the stock. Royal Bank of Canada initiated coverage on Ardent Health Partners in a research report on Monday, August 12th. They set an “outperform” rating and a $23.00 target price on the stock. Citigroup initiated coverage on Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $21.00 target price on the stock. Morgan Stanley initiated coverage on Ardent Health Partners in a research report on Monday, August 12th. They set an “overweight” rating and a $27.00 target price on the stock. Finally, Loop Capital began coverage on Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $18.00 target price on the stock. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Ardent Health Partners currently has an average rating of “Buy” and a consensus target price of $21.82.

Ardent Health Partners Stock Down 2.8 %

Ardent Health Partners stock traded down $0.50 during trading hours on Tuesday, hitting $17.31. The stock had a trading volume of 14,792 shares, compared to its average volume of 369,450. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a 1-year low of $14.57 and a 1-year high of $20.72. The firm has a fifty day simple moving average of $18.27.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings data on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.05. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Analysts predict that Ardent Health Partners will post 1.25 EPS for the current fiscal year.

Institutional Investors Weigh In On Ardent Health Partners

Several hedge funds have recently modified their holdings of ARDT. BNP Paribas Financial Markets acquired a new stake in Ardent Health Partners during the 3rd quarter valued at approximately $42,000. Financial Management Professionals Inc. acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $50,000. MetLife Investment Management LLC acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $135,000. Centiva Capital LP acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $469,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $526,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.